Department of
Internal Medicine at Highland Hospital
A member of Alameda Health System

Faculty


Return to Faculty List
Kevin Knopf, MD

Undergraduate School:

Massachusetts Institute of Technology

Graduate School:

Johns Hopkins School of Public Health

Medical School:

University of California, San Francisco

Residency:

 Northwestern

Fellowship:

National Cancer Institute

Research Interest:

I conduct research in patterns and quality of care, economic analysis of care, and decision analysis related to scenarios in Oncology and Hematology.

Recent Publications:

Noxon V, Knopf K, Norris L, Chen B, Yang YT, Quereshi Z, et al. A Tale of Two Erythropoiesis Stimulating Agents (ESAs): Utilization, dosing, litigation, and costs of Darbepoetin and Epoeitin among South Carolina Medicaid-Covered cancer patients with chemotherapy induced anemia. Journal of Oncology Practice 2017;13(6)e562-573

Knopf K, Baum M, Shimp WS ,Bennett CL et al. Interpretation of surrogate endpoints in the era of the 21st Century Cures Act. BMJ 2016;355;i6286

Divino V, Karve S, Gaughan A, DeKoven M, Knopf K and Lansa M, Patient characteristics and treatment patterns with hairy cell leukemia in the United States : a retrospective claims database analysis, accepted Leukemia/Lymphoma 2016

Lang K, McGarry LJ, Huang H, Dorer, D, Kaufman E, and Knopf K.  Mortality and vascular events among elderly patients with chronic myeloid leukemia (CM): A retrospective analysis of linked SEER-Medicare data Clin Lymphoma Myeloma Leuk 2016 (5) 275-285

Knopf KB, Divino V, McGarry L et al. Economic burden of tyrosine kinase inhibitor treatment in chronic myeloid leukemia. Clin Lymphoma Myeloma Leukemia 2015 S2152-2650(15)